Market Cap (In KRW)
557.01 Billion
Revenue (In KRW)
154.82 Billion
Net Income (In KRW)
4.67 Billion
Avg. Volume
3.58 Million
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 8190.0-27300.0
- PE
- -
- EPS
- -
- Beta Value
- 0.693397
- ISIN
- KR7053030003
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Won-Seok Kim
- Employee Count
- -
- Website
- https://www.bi-nex.co.kr
- Ipo Date
- 2001-08-07
- Details
- BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. has a co-development partnership with Genexine, Inc. to develop COVID-19 vaccine. The company was founded in 1957 and is based in Incheon, South Korea.
More Stocks
-
026960Dong Suh Companies Inc.
026960
-
JMART
-
0436
-
GREZFGREE, Inc.
GREZF
-
BXRBF
-
IMTVImagination TV, Inc.
IMTV
-
298040
-
ANGELONEAngel One Limited
ANGELONE